动脉硬和心力衰竭与保存的射出小部分
1Division of Cardiology, Department of Internal Medicine, Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
Journal of Korean medical science
|June 18, 2024
概括
动脉硬是心力衰竭的关键因素,具有保存的射出分数 (HFpEF),影响诊断和结果. 降低动脉硬性可能会改善心径功能和患者在HFpEF的预后.
科学领域:
- 心血管医学 心血管医学
- 血管生物学 血管生物学
- 老年学是一门学科.
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭很常见,预后不佳.
- 动脉硬是血管衰老的标志物,越来越多地与HFpEF病理生理学有关.
- 高FpEF与高血压,糖尿病和肥胖等心血管风险因素有关.
研究的目的:
- 探索动脉硬性在HFpEF病理生理学中的作用.
- 突出动脉硬度在HFpEF中的诊断和预后价值.
- 审查针对动脉硬性的潜在干预措施,用于HFpEF管理.
主要方法:
- 在HFpEF中调查动脉硬性的研究的文献综述.
- 分析动脉刚性与心血管风险因素之间的关系.
- 检查针对动脉硬性的干预研究.
主要成果:
- 患有HFpEF的患者显示动脉硬度明显高于对照组.
- 动脉硬度有助于增加左心室余负荷和腹功能障碍.
- 减少动脉硬性的干预措施可能会改善透缩功能和结果.
结论:
- 动脉硬是HFpEF的一个关键因素,影响诊断,管理和预后.
- 需要进一步的研究,以充分阐明将动脉硬与HFpEF联系在一起的机制.
- 针对动脉硬性,为HFpEF提供了一个有希望的治疗策略.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
420
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
420
Heart Failure Drugs: Diuretics
363
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
363
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Heart Failure Drugs: Inotropic Agents
564
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
564


